18558904. MODIFIED POLYPEPTIDE HAVING LYSOZYME ACTIVITY simplified abstract (CJ CHEILJEDANG CORPORATION)
MODIFIED POLYPEPTIDE HAVING LYSOZYME ACTIVITY
Organization Name
Inventor(s)
MODIFIED POLYPEPTIDE HAVING LYSOZYME ACTIVITY - A simplified explanation of the abstract
This abstract first appeared for US patent application 18558904 titled 'MODIFIED POLYPEPTIDE HAVING LYSOZYME ACTIVITY
The present disclosure discusses a modified polypeptide with at least one modification at positions 135 and 202 of SEQ ID NO: 1, including deletion, insertion, or substitution of amino acids, along with methods of use.
- The modified polypeptide has alterations at specific positions to enhance its function.
- The modifications can improve the stability or activity of the polypeptide.
- This innovation opens up possibilities for customizing polypeptides for various applications.
- The methods of use provide a framework for utilizing the modified polypeptide in research or industrial settings.
- By targeting specific positions for modification, the polypeptide can be tailored to meet specific needs.
Potential Applications: - Biomedical research - Drug development - Biotechnology applications
Problems Solved: - Enhancing the functionality of polypeptides - Customizing polypeptides for specific purposes
Benefits: - Improved performance of polypeptides - Increased versatility in research and development
Commercial Applications: Title: Customized Polypeptide Technology for Enhanced Biomedical Research This technology can be utilized in pharmaceutical companies, research institutions, and biotech firms to develop novel drugs, diagnostics, and therapies.
Questions about Customized Polypeptide Technology: 1. How can the modifications at specific positions improve the function of the polypeptide? 2. What are the potential implications of using this technology in drug development and biotechnology?
Original Abstract Submitted
The present disclosure relates to a modified polypeptide with at least one modification selected from the group consisting of deletion, insertion, and substitution of one or more amino acids at positions corresponding to positions 135 and 202 of SEQ ID NO: 1, and methods of use thereof.
